José Martinez returns to the beginnings of his improbable ascent and lays out his vision for a more resonant future for ...
SpaceX’s Falcon 9 launches 29 Starlink satellites from Florida, with the booster returning to a droneship and the mission adding to 2025’s launch count ...
Neon Giant, Swedish developer of cyberpunk shooter-RPG The Ascent, has unveiled its new game No Law at The Game Awards ...
Neon Giant’s debut project, The Ascent, dropped players into an isometric action game hosted by a neon world of crime and ...
No Law 's take on the cyberpunk genre — they call it "cyber-noire" — leans more toward immersive sim and story-based, ...
Fresh from its reveal at The Game Awards 2025, first-person open world shooter RPG No Law is already raising eyebrows for ...
Manchester United have made signing a midfielder priority number one.
SAN ANTONIO -- The antibody-drug conjugate (ADC) sacituzumab govitecan (Trodelvy) failed to outperform chemotherapy as first ...
With not one but three massive hits, sombr was one of 2025’s biggest breakouts — and the hardworking pop-rock wunderkind is determined to maintain his momentum.
Sacituzumab govitecan maintained physical functioning scores, contrasting with chemotherapy's deterioration in advanced TNBC patients. Time to deterioration in fatigue was comparable between ...
Sacituzumab govitecan failed to extend PFS in patients with hormone receptor-positive, HER2-negative breast cancer following ...
Sacituzumab does not improve outcomes vs chemotherapy when used as the first treatment after endocrine therapy failure in HR+/HER2- advanced breast cancer, the ASCENT-07 trial finds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results